The first step for understanding the molecular mechanism of the antifibrotic effect of inhaling 25(OH)-vitamin D3 and 1,25(OH)2-vitamin D3 in the murine model of hypersensitivity pneumonitis

IntroductionPulmonary fibrosis occurs in several respiratory diseases, among which hypersensitivity pneumonitis (HP) is often ignored in designing therapeutic strategies. We strive to fill these knowledge gaps. Our earlier studies revealed antifibrotic potential of the inhalation of 1,25(OH)2-VD3 an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marta Kinga Lemieszek, Michał Chojnacki, Iwona Paśnik, Alicja Wilczyńska, Wiktoria Gawryś, Jakub Anisiewicz, Ilona Leśniowska, Michał Kiełbus
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-08-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	pulmonary fibrosis hypersensitivity pneumonitis epithelial–mesenchymal transition calcidiol calcitriol animal models
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1610165/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!